Wednesday, June 22, 2005

Animal Rights Extremism a Priority for FBI

Do they know that not one person has been killed in acts by the ALF? But yet, how many anti-choice wackos have killed doctors or others? Who are the real terrorists? This seems to me based only on money.

http://news.yahoo.com/s/ap/20050621/ap_on_bi_ge/biotech_conference

By PAUL ELIAS, AP Biotechnology WriterTue Jun 21, 1:53 AM ET

Violence by environmental and animal rights extremists against U.S. drug makers has increased so much in recent years that it's currently the FBI's top domestic terrorism issue, a top agency official says.

"There has been an increase in the use of incendiary devices as well as explosive devices," said John Lewis, FBI deputy assistant director in charge of counterterrorism. "There's a very clear indication that there's no move to slow down or stop — in fact, just the opposite is true."

The agency has about 150 open cases of arson, bombings and other violent crimes associated with militant environmental and animal rights activists protesting the experimental use of animals in medical research, he said.

Lewis made the comments Monday in an address to some of the 18,000 biotechnology executives gathered here at the four-day Biotechnology Industry Organization's annual convention.

Some of the same groups associated with the wave of violent attacks on biotechnology companies said they planned demonstrations outside the convention center Tuesday.

Though the protesters vowed to be peaceful, convention organizers and Philadelphia police were taking no chances.

Security was high inside and outside the convention center. A helicopter hovered over the National Constitution Center on Sunday night while police on the ground formed a corridor through a small smattering of jeering demonstrators to ensure the conventioneers could arrive unmolested to a party inside.

Meanwhile, as the attacks nationwide increase along with hits to companies' bottom lines and worker morale, industry leaders and their crisis consultants are advocating a radical shift in strategy. They are beginning to fight back aggressively.

Chiron Corp. of Emeryville, Calif., which was bombed in 2003 and is still the subject of actions that include credit card fraud against some of its employees, won a restraining order in a California court against a group allegedly involved in much of the activity. The company also refused to renounce its ties to the protesters main target: Huntingdon Life Sciences, a Millstone, N.J. laboratory that does animal experiments for biotech and drug companies.

"We believe if we just kept our heads down, it would go away," said John Gallagher, director of Chiron's corporate communications. "That was unrealistic."

Gallagher said the attacks have cost Chiron at least $2.5 million, much of it associated with heightened security at public company events such as analyst meetings.

"That money would have been much better spent on drug development," Gallagher said.

The FBI is searching for the fugitive Daniel Andreas San Diego, who has been charged with the Chiron bombing and another at a Pleasanton, Calif. cosmetic maker. Neither bombing wrought serious damage or injuries.

San Diego has ties to several animal rights groups, including one called Stop Huntingdon Animal Cruelty, which is better known as SHAC.

SHAC and its adherents have waged a decade-long campaign against Huntingdon Life Sciences. Some of the tactics used against Huntingdon and the companies it contracts with include the vandalizing of executives' cars and houses, harassing employees and their families and the posting of personal information on public Web sites.

Six SHAC members face federal charges of conspiracy and interstate stalking that carry maximum penalties of between three and five years, plus fines up to $250,000. They are charged under the federal Animal Enterprise Protection Act, a 1992 law that was expanded in 2002 and equates their alleged activities with domestic terrorism.

A judge in Trenton, N.J., declared a mistrial in the case Monday after the lawyer for one of the defendants was too ill to continue with the trial. The case is not likely to come to trial before September, said Michael Drewniak, a spokesman for the U.S. Attorney's Office.

No comments:

Search for More Content

Custom Search
Bookmark and Share

Past Articles